VLA 0.00% $1.75 viralytics limited

Gilead buys Kite Pharma for $11.9 BN

  1. 343 Posts.
    lightbulb Created with Sketch. 23
    Offer was a 29% increase to Kite's closing price on Friday....
    I've read that this is a new class of drug but to be used in the field on oncology and will be used with other immunotherapies.
    Hoping that this is a good sign for Cavatak and VLA and there is still a huge appetite for cancer therapies!
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.